Live Breaking News & Updates on தேசிய தடுப்பூசி சீரம் நிறுவனம்|Page 2

Stay updated with breaking news from தேசிய தடுப்பூசி சீரம் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

China approves new COVID-19 vaccine for clinical trials


CHINA / SOCIETY
By Xinhua Published: Apr 11, 2021 08:30 AM
People receive COVID-19 vaccine at a vaccination site in Gulou District of Nanjing, east China s Jiangsu Province, April 9, 2021.(Photo: Xinhua)
 
A new COVID-19 vaccine developed by China s Sinopharm has recently been approved for clinical trials.
The new recombinant COVID-19 vaccine, developed by the National Vaccine & Serum Institute, a R&D center of Sinopharm s bioscience subsidiary the China National Biotec Group (CNBG), got approval from the National Medical Products Administration on Friday, the CNBG said on its official Weibo account on Saturday.
The vaccine is based on the structural features of the receptor binding domain (RBD) on the virus spike protein (S-protein). It uses genetic engineering to grow harmless copies of the virus S-protein to induce neutralizing antibodies. ....

Products Institute Co Ltd , China National Biotec Group , National Health Commission , National Medical Products Administration On , National Vaccine Serum Institute , Wuhan Institute Of Biological Products , Gulou District , Jiangsu Province , National Vaccine , Serum Institute , National Medical Products Administration , Wuhan Institute , Biological Products , ப்ராடக்ட்ஸ் நிறுவனம் இணை லிமிடெட் , சீனா தேசிய பயோடெக் குழு , தேசிய ஆரோக்கியம் தரகு , தேசிய தடுப்பூசி சீரம் நிறுவனம் , தேசிய தடுப்பூசி , சீரம் நிறுவனம் , உயிரியல் ப்ராடக்ட்ஸ் ,